RXRX stock forecast
Our latest prediction for Recursion Pharmaceuticals Inc Class A - RXRX's stock price was made on the Feb. 22, 2023 when the stock price was at 7.94$.
In the short term (2weeks), RXRX's stock price should underperform the market by -0.82%. During that period the price should oscillate between -7.99% and +5.67%.
In the medium term (3months), RXRX's stock price should underperform the market by -4.82%. During that period the price should oscillate between -25.45% and +10.75%.
Get email alertsCreate a solid portfolio with RXRX
About Recursion Pharmaceuticals Inc Class A - RXRX
At the moment the company generates 164M USD in revenues.
On its last earning announcement, the company reported a loss of -1.34$ per share.
The book value per share is -1.27$
Three months stock forecastFeb. 22, 2023
Financials
| Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 164M | -5.29% | -249M | -151.74% | -246M | -1.34 | - | - | 174M | -1.27 | - | - | - |